NEOS - Neos Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

Neos Therapeutics's activity chart (see below) currently has 18 price targets and 23 ratings on display.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 19.44% of the time, taking 81.83 days on average.

Most recent stock forecast was given by from RAYMOND JAMES on 10-Nov-2020. First documented stock forecast 12-Nov-2015.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 10-Aug-2018

$1

6 years 11 days ago
(10-Nov-2020)

1/6 (16.67%)

$0.47 (88.68%)

91

Buy Since 18-Sep-2017

6 years 11 days ago
(10-Nov-2020)

0/2 (0%)

$7.55 (308.16%)

Buy Since 31-Jul-2017

$20

7 years 5 months 9 days ago
(12-Jun-2019)

0/1 (0%)

$13.55 (210.08%)

Buy Since 18-Oct-2017

$6

$11

8 years 7 days ago
(14-Nov-2018)

0/4 (0%)

$3.95 (192.68%)

Buy Since 26-Oct-2017

$20

$20

9 years 26 days ago
(26-Oct-2017)

0/2 (0%)

$9.95 (99.00%)

Show more analysts

Please expand the browser size to see the chart

What is NEOS (Neos Therapeutics) average time for price targets to be met?

On average it took 82 days for the stock forecasts to be reached, with an average price target met ratio of 19.44%.

Which analyst most recently updated their price target on NEOS (Neos Therapeutics)?

Which analyst has the most public recommendations on NEOS (Neos Therapeutics)?

has 0 price targets and 0 ratings on NEOS

Which analyst is the currently most bullish on NEOS (Neos Therapeutics)?

Tyler Van Buren with the highest potential upside of $18.85

Which analyst is the currently most reserved on NEOS (Neos Therapeutics)?

Gary Nachman with the lowest potential downside of -$0.15
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?